Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of HPV L1 Vaccine in Combination With Imiquimod and Metformin in Cervical, Vaginal, and Vulvar Cancers

NCT06686043 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT06686043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06686043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of HPV L1 Vaccine in Combination With Imiquimod and Metformin in Cervical, Vaginal, and Vulvar Cancers
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Recruiting
Start date
August 23, 2024
Completion date
August 23, 2028
Enrollment
85 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical carcinoma, hpv (human papillomavirus)-associated carcinoma, vaginal carcinoma, vulvar carcinoma